222 related articles for article (PubMed ID: 31545988)
1. Neurological and psychiatric adverse effects of long-term methylphenidate treatment in ADHD: A map of the current evidence.
Krinzinger H; Hall CL; Groom MJ; Ansari MT; Banaschewski T; Buitelaar JK; Carucci S; Coghill D; Danckaerts M; Dittmann RW; Falissard B; Garas P; Inglis SK; Kovshoff H; Kochhar P; McCarthy S; Nagy P; Neubert A; Roberts S; Sayal K; Sonuga-Barke E; Wong ICK; Xia J; Zuddas A; Hollis C; Konrad K; Liddle EB;
Neurosci Biobehav Rev; 2019 Dec; 107():945-968. PubMed ID: 31545988
[TBL] [Abstract][Full Text] [Related]
2. Osmotic Release Oral System Methylphenidate Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Chinese Youth: 8-Week Comparative Efficacy and 1-Year Follow-Up.
Su Y; Yang L; Stein MA; Cao Q; Wang Y
J Child Adolesc Psychopharmacol; 2016 May; 26(4):362-71. PubMed ID: 26779845
[TBL] [Abstract][Full Text] [Related]
3. Association Between 5-HTTLPR Polymorphism and Tics after Treatment with Methylphenidate in Korean Children with Attention-Deficit/Hyperactivity Disorder.
Park SY; Kim EJ; Cheon KA
J Child Adolesc Psychopharmacol; 2015 Oct; 25(8):633-40. PubMed ID: 26402385
[TBL] [Abstract][Full Text] [Related]
4. [Supervised off-label prescribing of methylphenidate in adult ADHD].
Carton L; Dondaine T; Deheul S; Marquié C; Brigadeau F; Amad A; Devos D; Danel T; Bordet R; Cottencin O; Gautier S; Ménard O
Encephale; 2019 Feb; 45(1):74-81. PubMed ID: 30122296
[TBL] [Abstract][Full Text] [Related]
5. Relationship Between Aggravation of Seizures and Methylphenidate Treatment in Subjects with Attention-Deficit/Hyperactivity Disorder and Epilepsy.
Park J; Choi HW; Yum MS; Ko TS; Shon SH; Kim HW
J Child Adolesc Psychopharmacol; 2018 Oct; 28(8):537-546. PubMed ID: 30089215
[TBL] [Abstract][Full Text] [Related]
6. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
Epstein T; Patsopoulos NA; Weiser M
Cochrane Database Syst Rev; 2014 Sep; (9):CD005041. PubMed ID: 25230710
[TBL] [Abstract][Full Text] [Related]
7. An update on the safety of psychostimulants for the treatment of attention-deficit/hyperactivity disorder.
Groenman AP; Schweren LJ; Dietrich A; Hoekstra PJ
Expert Opin Drug Saf; 2017 Apr; 16(4):455-464. PubMed ID: 28277842
[TBL] [Abstract][Full Text] [Related]
8. Testicular Function After Long-Term Methylphenidate Treatment in Boys with Attention-Deficit/Hyperactivity Disorder.
Wang LJ; Lee SY; Chou WJ; Lee MJ; Tsai CS; Lee TL; Yang CJ; Yang KC; Chen CK; Shyu YC
J Child Adolesc Psychopharmacol; 2019 Aug; 29(6):433-438. PubMed ID: 30575416
[No Abstract] [Full Text] [Related]
9. Methylphenidate in Adults with Attention Deficit Hyperactivity Disorder and Substance Use Disorders.
Simon N; Rolland B; Karila L
Curr Pharm Des; 2015; 21(23):3359-66. PubMed ID: 26088112
[TBL] [Abstract][Full Text] [Related]
10. Effects of methylphenidate on body index and physical fitness in Korean children with attention deficit hyperactivity disorder.
Kang KD; Yun SW; Chung U; Kim TH; Park JH; Park IH; Han DH
Hum Psychopharmacol; 2016 Mar; 31(2):76-82. PubMed ID: 26756111
[TBL] [Abstract][Full Text] [Related]
11. [Cardiovascular risks and management during Attention Deficit Hyperactivity Disorder treatment with methylphenidate].
Bange F; Le Heuzey MF; Acquaviva E; Delorme R; Mouren MC
Arch Pediatr; 2014 Jan; 21(1):108-12. PubMed ID: 24309201
[TBL] [Abstract][Full Text] [Related]
12. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
[TBL] [Abstract][Full Text] [Related]
13. Once-daily OROS methylphenidate is safe and well tolerated in adolescents with attention-deficit/hyperactivity disorder.
McGough JJ; McBurnett K; Bukstein O; Wilens TE; Greenhill L; Lerner M; Stein M
J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):351-6. PubMed ID: 16768642
[TBL] [Abstract][Full Text] [Related]
14. An expert opinion on methylphenidate treatment for attention deficit hyperactivity disorder in pediatric patients with epilepsy.
Baptista-Neto L; Dodds A; Rao S; Whitney J; Torres A; Gonzalez-Heydrich J
Expert Opin Investig Drugs; 2008 Jan; 17(1):77-84. PubMed ID: 18095920
[TBL] [Abstract][Full Text] [Related]
15. Use and Characteristics of Antipsychotic/Methylphenidate Combination Therapy in Children and Adolescents with a Diagnosis of Attention-Deficit/Hyperactivity Disorder.
Scholle O; Banaschewski T; Enders D; Garbe E; Riedel O
J Child Adolesc Psychopharmacol; 2018; 28(6):415-422. PubMed ID: 29768038
[TBL] [Abstract][Full Text] [Related]
16. A randomized crossover clinical study showing that methylphenidate-SODAS improves attention-deficit/hyperactivity disorder symptoms in adolescents with substance use disorder.
Szobot CM; Rohde LA; Katz B; Ruaro P; Schaefer T; Walcher M; Bukstein O; Pechansky F
Braz J Med Biol Res; 2008 Mar; 41(3):250-7. PubMed ID: 18327433
[TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy and safety of methylphenidate and atomoxetine for attention-deficit hyperactivity disorder in children and adolescents: Meta-analysis based on head-to-head trials.
Liu Q; Zhang H; Fang Q; Qin L
J Clin Exp Neuropsychol; 2017 Nov; 39(9):854-865. PubMed ID: 28052720
[TBL] [Abstract][Full Text] [Related]
18. Emergence of tics in children with ADHD: impact of once-daily OROS methylphenidate therapy.
Palumbo D; Spencer T; Lynch J; Co-Chien H; Faraone SV
J Child Adolesc Psychopharmacol; 2004; 14(2):185-94. PubMed ID: 15319016
[TBL] [Abstract][Full Text] [Related]
19. No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy.
Walitza S; Kämpf K; Artamonov N; Romanos M; Gnana Oli R; Wirth S; Warnke A; Gerlach M; Stopper H
Toxicol Lett; 2009 Jan; 184(1):38-43. PubMed ID: 19015014
[TBL] [Abstract][Full Text] [Related]
20. Guidelines and algorithms for the use of methylphenidate in children with Attention-Deficit/ Hyperactivity Disorder.
Greenhill L; Beyer DH; Finkleson J; Shaffer D; Biederman J; Conners CK; Gillberg C; Huss M; Jensen P; Kennedy JL; Klein R; Rapoport J; Sagvolden T; Spencer T; Swanson JM; Volkow N
J Atten Disord; 2002; 6 Suppl 1():S89-100. PubMed ID: 12685523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
